Monday, January 17, 2022

2-DG drug

DRDO invites EoI to transfer technology of 2-DG drug for bulk production

2-DG was developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO, in collaboration with Dr Reddy's Laboratories.

DRDO’s 2-DG drug to help combat Covid

The drug can be added as a supplement or adjunct to the existing treatment protocols to treat moderate to severe Covid patients

Latest News

- Advertisement -